Clinical exome sequencing: results from 2819 samples reflecting 1000 families

We report our results of 1000 diagnostic WES cases based on 2819 sequenced samples from 54 countries with a wide phenotypic spectrum. Clinical information given by the requesting physicians was translated to HPO terms. WES processes were performed according to standardized settings. We identified the underlying pathogenic or likely pathogenic variants in 307 families (30.7%). In further 253 families (25.3%) a variant of unknown significance, possibly explaining the clinical symptoms of the index patient was identified. WES enabled timely diagnosing of genetic diseases, validation of causality of specific genetic disorders of PTPN23, KCTD3, SCN3A, PPOX, FRMPD4, and SCN1B, and setting dual diagnoses by detecting two causative variants in distinct genes in the same patient. We observed a better diagnostic yield in consanguineous families, in severe and in syndromic phenotypes. Our results suggest that WES has a better yield in patients that present with several symptoms, rather than an isolated abnormality. We also validate the clinical benefit of WES as an effective diagnostic tool, particularly in nonspecific or heterogeneous phenotypes. We recommend WES as a first-line diagnostic in all cases without a clear differential diagnosis, to facilitate personal medical care.

[1]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[2]  Claire Redin,et al.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. , 2013, American journal of human genetics.

[3]  Nigel Collier,et al.  Automatic concept recognition using the Human Phenotype Ontology reference and test suite corpora , 2015, Database J. Biol. Databases Curation.

[4]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[5]  Davis J. McCarthy,et al.  Factors influencing success of clinical genome sequencing across a broad spectrum of disorders , 2015, Nature Genetics.

[6]  Jonathan A. Bernstein,et al.  Clinical whole-exome sequencing: are we there yet? , 2014, Genetics in Medicine.

[7]  F. Alkuraya,et al.  High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders , 2015, Human Genetics.

[8]  D. Trujillano,et al.  Asparagine Synthetase Deficiency: New Inborn Errors of Metabolism. , 2015, JIMD reports.

[9]  Y. Kuroda,et al.  Delineation of the KIAA2022 mutation phenotype: Two patients with X‐linked intellectual disability and distinctive features , 2015, American journal of medical genetics. Part A.

[10]  M. Meisler,et al.  Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy , 2008, Neuroscience Letters.

[11]  M J Khoury,et al.  Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. , 1997, Archives of pediatrics & adolescent medicine.

[12]  N. Nukina,et al.  A Functional Null Mutation of SCN1B in a Patient with Dravet Syndrome , 2009, The Journal of Neuroscience.

[13]  M A Whelen,et al.  Practice parameter: Evaluation of the child with global developmental delay , 2003, Neurology.

[14]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[15]  S. McCandless,et al.  The burden of genetic disease on inpatient care in a children's hospital. , 2004, American journal of human genetics.

[16]  S. Holden,et al.  Homozygous variegate porphyria presenting with developmental and language delay in childhood , 2013, Clinical and experimental dermatology.

[17]  D. Goldstein,et al.  Practical considerations in the clinical application of whole‐exome sequencing , 2016, Clinical genetics.

[18]  L. Vissers,et al.  Genome sequencing identifies major causes of severe intellectual disability , 2014, Nature.

[19]  D. Trujillano,et al.  A homozygous nonsense variant in IFT52 is associated with a human skeletal ciliopathy , 2016, Clinical genetics.

[20]  Eric Vilain,et al.  Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.

[21]  J. Lupski,et al.  Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy , 2013, Genome Medicine.

[22]  M. Gingold,et al.  CME Practice parameter : Evaluation of the child with global developmental delay , 2003 .

[23]  M. Samuels.  Saturation of the Human Phenome , 2010, Current genomics.

[24]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[25]  H B Newcombe,et al.  Genetic disorders in children and young adults: a population study. , 1988, American journal of human genetics.

[26]  Allyn McConkie-Rosell,et al.  The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders , 2013, Genetics in Medicine.

[27]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[28]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[29]  A. Zharkikh,et al.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.

[30]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[31]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[32]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[33]  A. George,et al.  Novel SCN3A variants associated with focal epilepsy in children , 2014, Neurobiology of Disease.

[34]  Steven J. M. Jones,et al.  FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. , 2014, American journal of human genetics.

[35]  S. Ashwal,et al.  CME Practice parameter : Evaluation of children and adolescents with recurrent headaches Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society , 2002 .

[36]  Z. Nawaz,et al.  Whole exome sequencing unravels disease‐causing genes in consanguineous families in Qatar , 2014, Clinical genetics.

[37]  T. Beaty,et al.  Whole Exome Sequencing of Distant Relatives in Multiplex Families Implicates Rare Variants in Candidate Genes for Oral Clefts , 2014, Genetics.

[38]  S. Antonarakis,et al.  Diagnostic Exome Sequencing to Elucidate the Genetic Basis of Likely Recessive Disorders in Consanguineous Families , 2014, Human mutation.

[39]  K. Friend,et al.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes , 2015, Molecular Psychiatry.

[40]  Mohamed Abouelhoda,et al.  Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. , 2015, Cell reports.

[41]  T. Walsh,et al.  Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing , 2010, Proceedings of the National Academy of Sciences.